FN2 Earnings Intelligence
Repligen Corporation ratios (quarterly)
Repligen Corporation (RGEN) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $697.2 | $708.9 | $748.7 | $582.6 | $606.8 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $169.2 | $182.4 | $188.8 | $194.3 | $204.1 |
| % Growth | - | - | - | - | - |
| Gross Profit | $90.8 | $91.1 | $100.5 | $108.3 | $110 |
| % Margin | 53.6% | 50.0% | 53.2% | 55.7% | 53.9% |
| EBITDA | $25.3 | - | - | $35.7 | - |
| % Margin | 14.9% | - | - | 18.4% | - |
| Net Income | $5.8 | $14.9 | $14.9 | $8.3 | $5 |
| % Margin | 3.4% | 8.2% | 7.9% | 4.3% | 2.5% |
| Diluted EPS | $0.10 | $0.26 | $0.26 | $0.15 | $0.09 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | $15 | - | - | $28.3 | - |
| CapEx | $3.6 | - | - | $4.7 | - |
| Free Cash Flow | $11.4 | - | - | $23.6 | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue | $169.2 | $182.4 | $188.8 | $194.3 | $204.1 |
| Gross Profit | $90.8 | $91.1 | $100.5 | $108.3 | $110 |
| EBITDA | $25.3 | - | - | $35.7 | - |
| Net Income | $5.8 | $14.9 | $14.9 | $8.3 | $5 |
| Diluted EPS | $0.10 | $0.26 | $0.26 | $0.15 | $0.09 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $697.2 | $708.9 | $748.7 | $582.6 | $606.8 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $529.6 | $533.7 | $537.9 | $546.6 | $551 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $15 | - | - | $28.3 | - |
| Capital Expenditure | $3.6 | - | - | $4.7 | - |
| Free Cash Flow | $11.4 | - | - | $23.6 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 53.6% | 50.0% | 53.2% | 55.7% | 53.9% |
| EBITDA Margin | 14.9% | - | - | 18.4% | - |
| Net Margin | 3.4% | 8.2% | 7.9% | 4.3% | 2.5% |
| FCF Margin | 6.8% | - | - | 12.1% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the RGEN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.